SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift - 2New law puts familiar drinks, creams and gummies in legal limbo
- 3Winter virus season so far is not too bad, but doctors worry about suffering to come
- 4South African army arrive in crime hotspots to help tackle gangs
- 510 Moves toward Start Your Own Effective Business
- I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
- Picking the Right Home Machines: A Commonsense Aide
- Turkey key underlying issue as Israel, Greece, Cyprus hold summit
- Find Unexpected, yet invaluable treasure Excursion Rentals
- 5 Must-Attempt Fascinating Dishes from Around the World
- Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- Four new luxury hotel openings in Italy you need to know about
- The Best Internet based Retailers for Style and Frill
